Thursday, May 2, 2019

ResMed reports Q3 adjusted EPS 89c, consensus 85c

Reports Q3 revenue $662.2M, consensus $. Q3 gross margin expanded 100bps to 59.2%.
at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.